The Implantable Cardioverter Defibrillator Remains the First Choice for Primary Prevention of Sudden Death in Non-Ischemic Dilated Cardiomyopathy in the Current Era of Treatment
pp. 212-219
Downloads
Published
2025-07-28
Issue
Section
CONTROVERSIAS
License
Copyright (c) 2025 Argentine Journal of Cardiology

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.







